Moog Announces Medical Devices Acquisition Closing
March 16 2007 - 5:15PM
PR Newswire (US)
EAST AURORA, N.Y., March 16 /PRNewswire-FirstCall/ -- Moog Inc.
(NYSE:MOG.ANYSE:andNYSE:MOG.B) (the "Company") announced today that
it has completed the acquisition of ZEVEX International Inc.
(NASDAQ:ZVXI) for $83.8 million. ZEVEX is a manufacturer of medical
devices headquartered in Salt Lake City, Utah. ZEVEX shareholders
will receive $13 in cash for each share of ZEVEX common stock. As a
result of this transaction, ZEVEX is now a wholly owned subsidiary
of Moog. The Company used its revolving credit facility to finance
the transaction. ZEVEX manufacturers and distributes a line of
ambulatory pumps, stationary pumps, and disposable sets that are
used in the delivery of enteral nutrition for hospital, nursing
home, neonatal, and patient home use. In addition, ZEVEX designs,
develops, and manufactures surgical tools and sensors, and provides
engineered solutions for the medical marketplace. The Company
employs a staff of 178 people. This acquisition expands Moog's
participation in the medical devices market. In the fiscal year
ending September 29, 2007, sales in Moog's Medical Devices segment
will approach $65 million, including $25 million in ZEVEX sales
over the next six months. Due to first-year purchase accounting
adjustments, this acquisition will be neutral to Moog's earnings
per share for FY 2007. "We're excited about having ZEVEX become
part of our Company," said Robert T. Brady, Chairman and CEO. "We
believe that ZEVEX brings an outstanding combination of personnel
and products that further extend Moog's capabilities in the medical
market, enabling us to continue growing this business." Moog Inc.
is a worldwide designer, manufacturer, and integrator of precision
control components and systems. Moog's high-performance systems
control military and commercial aircraft, satellites and space
vehicles, launch vehicles, missiles, automated industry machinery,
and medical equipment. Cautionary Statement Information included
herein or incorporated by reference that does not consist of
historical facts, including statements accompanied by or containing
words such as "may," "will," "should," "believes," "expects,"
"expected," "intends," "plans," "projects," "estimates,"
"predicts," "potential," "outlook," "forecast," "anticipates,"
"presume" and "assume," are forward- looking statements. Such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
These statements are not guarantees of future performance and are
subject to several factors, risks and uncertainties, the impact or
occurrence of which could cause actual results to differ materially
from the expected results described in the forward-looking
statements. These important factors, risks and uncertainties
include (i) fluctuations in general business cycles for commercial
aircraft, military aircraft, space and defense products, industrial
capital goods and medical devices, (ii) our dependence on
government contracts that may not be fully funded or may be
terminated, (iii) our dependence on certain major customers, such
as The Boeing Company and Lockheed Martin, for a significant
percentage of our sales, (iv) the possibility that the demand for
our products may be reduced if we are unable to adapt to
technological change, (v) intense competition which may require us
to lower prices or offer more favorable terms of sale, (vi) our
significant indebtedness which could limit our operational and
financial flexibility, (vii) the possibility that new product and
research and development efforts may not be successful which could
reduce our sales and profits, (viii) increased cash funding
requirements for pension plans, which could occur in future years
if future plan results differ from assumptions used for our defined
benefit pension plans, including returns on plan assets and
discount rates, (ix) a write-off of all or part of our goodwill,
which could adversely affect our operating results and net worth
and cause us to violate covenants in our bank agreements, (x) the
potential for substantial fines and penalties or suspension or
debarment from future contracts in the event we do not comply with
regulations relating to defense industry contracting, (xi) the
potential for cost overruns on development jobs and fixed price
contracts and the risk that actual results may differ from
estimates used in contract accounting, (xii) the possibility that
our subcontractors may fail to perform their contractual
obligations, which may adversely affect our contract performance
and our ability to obtain future business, (xiii) our ability to
successfully identify and consummate acquisitions, and integrate
the acquired businesses and the risks associated with acquisitions,
including that the acquired businesses do not perform in accordance
with our expectations, and that we assume unknown liabilities in
connection with the acquired businesses for which we are not
indemnified, (xiv) our dependence on our management team and key
personnel, (xv) the possibility of a catastrophic loss of one or
more of our manufacturing facilities, (xvi) the possibility that
future terror attacks, war or other civil disturbances could
negatively impact our business, (xvii) our operations in foreign
countries could expose us to political risks and adverse changes in
local, legal, tax and regulatory schemes, (xviii) the possibility
that government regulation could limit our ability to sell our
products outside the United States, (xix) the impact of product
liability claims related to our products used in applications where
failure can result in significant property damage, injury or death
and in damage to our reputation, (xx) the possibility that
litigation may result unfavorably to us, (xxi) foreign currency
fluctuations in those countries in which we do business and other
risks associated with international operations and (xxii) the cost
of compliance with environmental laws. The factors identified above
are not exhaustive. New factors, risks and uncertainties may emerge
from time to time that may affect the forward-looking statements
made herein. Given these factors, risks and uncertainties,
investors should not place undue reliance on forward-looking
statements as predictive of future results. We disclaim any
obligation to update the forward-looking statements made in this
report. DATASOURCE: Moog Inc. CONTACT: Ann Marie Luhr, of Moog
Inc., +1-716-687-4225
Copyright
Zevex (NASDAQ:ZVXI)
Historical Stock Chart
From Dec 2024 to Jan 2025
Zevex (NASDAQ:ZVXI)
Historical Stock Chart
From Jan 2024 to Jan 2025